Standout Papers

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant 1991 2026 2002 2014 777
  1. Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant (1991)
    Robert L. Martuza, Amy Malick et al. Science
  2. Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study (2013)
    Yaël P. Mossé, Megan S. Lim et al. The Lancet Oncology

Immediate Impact

4 by Nobel laureates 15 from Science/Nature 64 standout
Sub-graph 1 of 22

Citing Papers

Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
CAR T therapy beyond cancer: the evolution of a living drug
2023 StandoutNature
19 intermediate papers

Works of Katherine Ruffner being referenced

131I–anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission
2005
Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant
1991 StandoutScience

Author Peers

Author Last Decade Papers Cites
Katherine Ruffner 205 809 570 753 665 30 1.9k
Michel Barrois 121 969 378 446 1174 54 2.3k
Archibald S. Perkins 413 418 271 343 1167 42 2.3k
Wolfram Scheurlen 88 507 1033 507 1495 46 3.1k
Carmel M. Lynch 200 972 156 825 1088 21 2.5k
Meng-Fen Wu 109 1829 367 525 662 43 2.5k
Alfred P. Gillio 1046 1218 474 670 524 49 2.7k
Gregory T. O’Conor 88 1245 416 288 306 57 2.3k
Akira Hangaishi 991 583 358 493 1050 85 2.7k
William C. Manning 675 601 576 460 1287 27 3.0k
Lloyd Hutchinson 252 612 896 394 714 79 2.4k

All Works

Loading papers...

Rankless by CCL
2026